What is the equivalent hydromorphone continuous infusion dose for a fentanyl transdermal patch delivering 12 µg per hour?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fentanyl 12 mcg/hr Patch Equivalent to Oral Hydromorphone

A fentanyl 12 mcg/hr patch is approximately equivalent to 3.6 mg/day of oral hydromorphone (1.8 mg every 12 hours of Hydromorph Contin), but you should reduce this by 25-50% when converting to account for incomplete cross-tolerance, resulting in a starting dose of 1.8-2.7 mg/day total (approximately 3 mg every 12 hours of Hydromorph Contin). 1

Conversion Calculation

Using the NCCN guideline conversion table 1:

  • Fentanyl 12 mcg/hr patch falls below the lowest listed dose (25 mcg/hr)
  • The table shows: Fentanyl 25 mcg/hr = 7.5 mg/day oral hydromorphone
  • By proportional calculation: 12 mcg/hr = approximately 3.6 mg/day oral hydromorphone

Critical Dose Reduction Step

When rotating from fentanyl to hydromorphone, you must reduce the calculated equianalgesic dose by 25-50% to account for incomplete cross-tolerance between different opioids. 1 This is a crucial safety measure.

Final Recommended Dosing:

  • Calculated equianalgesic dose: 3.6 mg/day oral hydromorphone
  • After 25% reduction: 2.7 mg/day (approximately 3 mg twice daily)
  • After 50% reduction: 1.8 mg/day (approximately 3 mg once daily or 1.5 mg twice daily)

For Hydromorph Contin (extended-release hydromorphone dosed every 12 hours):

  • Start with 3 mg every 12 hours (total 6 mg/day) if pain was well-controlled on fentanyl
  • Start with 3 mg once daily (total 3 mg/day) if being more conservative or patient is frail

Important Clinical Considerations

Always provide breakthrough medication: Prescribe immediate-release hydromorphone (10% of total daily dose) for breakthrough pain during the conversion period. 1

Monitor closely during conversion: The fentanyl patch continues to deliver medication for 12-24 hours after removal due to the subcutaneous depot, so overlap effects are possible. 1

Titrate based on response: If pain control is inadequate after 2-3 days, increase the dose by 25-50% rather than returning to the full calculated equianalgesic dose. 1

Verification Using MME Calculations

Using CDC conversion factors 2, 3:

  • Fentanyl transdermal: multiply mcg/hr by 2.4 = 12 × 2.4 = 28.8 MME/day
  • Hydromorphone oral: multiply mg by 5 (using 2025 NCCN factor) 4
  • Therefore: 28.8 MME ÷ 5 = 5.76 mg oral hydromorphone/day
  • After 50% reduction: 2.9 mg/day (rounds to 3 mg twice daily)

This confirms the recommendation of starting with 3 mg every 12 hours of Hydromorph Contin after applying the mandatory dose reduction for opioid rotation.

References

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Guideline

adult cancer pain, version 2.2025, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.